Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question-Reference-Cited by-同舟云学术

Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

Published:2011-03-08 Issue:9 Volume:33 Page:1028-1035
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Orchard T. R.,van der Geest S. A. P.,Travis S. P. L.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04620.x/fullpdf

Reference16 articles.

1. Insights into patient and physician communication and expectations: results of a large pan-european survey of physicians and their patients with inflammatory bowel disease;Van Assche;J Crohn’s Colitis,2008

2. Ulcerative colitis: diagnosis and management;Collins;BMJ,2006

3. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey;Ghosh;J Crohn’s Colitis,2007

4. European evidence-based consensus on the management of ulcerative colitis: definitions and diagnosis;Stange;J Crohn’s Colitis,2008

5. The fight for ‘health-related normality’: a qualitative study of the experiences of individuals living with established inflammatory bowel disease (IBD);Hall;J Health Psychol,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

2. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

3. Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus;Journal of Clinical Medicine;2023-11-04

4. Consenso colombiano de la enfermedad inflamatoria intestinal pediátrica;Revista colombiana de Gastroenterología;2023-10-02

5. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08